The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
 
Aparna Raj Parikh
Consulting or Advisory Role - Driver, Inc; Eisai; Foundation Medicine; PureTech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); OncoMed (Inst); Plexxikon (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Eisai
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
Beow Y Yeap
No Relationships to Disclose
 
Jill N. Allen
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; MPM Capital; Oncorus
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Other Relationship - TCR2 Therapeutics
 
Bruce J. Giantonio
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Abbvie; Bayer; Celgene; Genentech/Roche; Lilly; Millennium
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Roche/Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Emily E. Van Seventer
No Relationships to Disclose
 
Lauren Matlack
No Relationships to Disclose
 
Bronwen Foreman
No Relationships to Disclose
 
Leilana Ly
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
David Tsai Ting
Stock and Other Ownership Interests - PanTher Therapeutics
Honoraria - Ventana Medical Systems
Consulting or Advisory Role - Merrimack
Research Funding - ACD Biotechne
Patents, Royalties, Other Intellectual Property - Patent licensed to PanTher Therapeutics by my institution (Partners Health care). No royalty payments have been received
 
Ryan Bruce Corcoran
Stock and Other Ownership Interests - Avidity Biosciences; nRichDx
Consulting or Advisory Role - Amgen; Array BioPharma; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; Chugai Pharma; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; nRichDx; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics; EMD Serono
Research Funding - AstraZeneca (Inst); clinical genomics (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)